EGFR and cancer: Aside from AS, lipid metabolism targeting creates new opportunities as cancer cells rely on cholesterol-rich areas (rafts) to support survival signals (such as the EGFR/PI3K pathways), cholesterol imbalance causes AS, and is associated with tumor growth [204].